{"id":"HHS-OASH-2026-0397-4005","number":"4005","name":"Steven Weller","organization":"","posted":"2026-10-21T04:00Z","received":"2026-10-15T04:00Z","body":"The attached submission draws on several complementary sources of evidence including peer-reviewed research, my own research and reports from government and intergovernmental bodies. These include the U.S. National Toxicology Program (NTP), the Federal Communications Commission (FCC) and Australian Radiation Protection and Nuclear Safety Agency (ARPANSA), the International Agency for Research on Cancer (IARC) and the World Health Organization (WHO). It also draws on an independent scoping review and evidence map of the RF-EMF genotoxicity literature, an independent assessment of the evidence concerning RF-EMF and cancer using the Bradford Hill viewpoints, and a comparative analysis of approaches adopted by two international radiation protection authorities.\nThe submission further incorporates an analysis of public submissions to the 2019-2020 Australian Parliamentary Inquiry on 5G. Symptoms reported by respondents to that inquiry are compared with symptoms reported in two smart-meter datasets: Lamech 2014, a peer-reviewed case series, and Halteman 2011, a survey report.\nFinally, the submission draws on my broader research into epistemic issues in evidence interpretation and the governance of scientific uncertainty. These analyses examine how differences in evidentiary frameworks, assumptions and approaches to uncertainty may contribute to divergent interpretations of the same body of evidence. Full citations are provided in the consolidated, numbered reference list at the end of the attached submission. \n\nOverview\nThe United States Human Health Services (HHS) has released an RFI that is effectively asking the following question: What does the evidence actually show about RF-EMF and human health, and are current RF-EMF guidelines/standards, surveillance systems and research priorities adequate? This submission answers this question from a position that will be unfamiliar to HHS in one respect: it does not treat the reassurance of ICNIRP, the WHO International EMF Project, or the FCC as a reliable proxy for “the science.” Those bodies are one set of institutional actors among several. The evidence set out below, includes animal carcinogenicity data, mechanistic and genotoxicity research, an analysis of a selection of WHO-commissioned systematic reviews (SRs) in 2024-25, the documented influence of funding sources on reported outcomes, and the history of how the WHO/IARC World Cancer Report has treated this evolving literature. Overall, it indicates that their settled position of safety reassurance is unjustified and that the evidence has not been treated as a neutral body of findings to be weighed impartially. Instead, the selection, characterization and relative weighing appear to have been influenced by the prevailing institutional interpretation of RF-EMF health risks in order to maintain regulatory status quo.\nImportantly, this submission does not claim that RF-EMF is a proven, established human carcinogen in the sense that tobacco smoke and ionizing radiation are proven carcinogens. It is a claim that the totality of the evidence, considered across animal, mechanistic, and epidemiological domains, and without deferring automatically to the institutions that have minimized it, is substantially stronger than “no evidence of harm”. It is also a claim that the governance structures that are currently responsible for setting limits are not well suited to registering that strength. The attached submission contains sections organized around the RFI’s own numbered questions and integrates two bodies of my own independent research: an evidence assessment of the RF-EMF cancer and genotoxicity literature, and an analysis of the governance and institutional dynamics that have shaped how the evidence has been used, or not used, in setting federal policy. Where both analyses converge on the same underlying point, for example, that funding source and institutional affiliation are more predictive of a study’s reported findings than its methodological quality, the evidence and the governance analysis are presented together rather than repeated separately, because the pattern is the same pattern viewed from two directions.\n","attachments":["https://downloads.regulations.gov/HHS-OASH-2026-0397-4005/attachment_1.pdf"],"attachment_inventory":true,"withheld":false,"source":"https://www.regulations.gov/comment/HHS-OASH-2026-0397-4005","tags":["cancer-tumors","health-experiences","exposure-places","policy-standards","research-evidence"],"source_hash":"de2799ce678f97628c66c8324bc7f82a039418691f72e7bd12fd92c5e395c6dc","slug":"cancer-tumors-comment-4005","classification":{"id":"HHS-OASH-2026-0397-4005","body_sha256":"ef5f722662d23b5eb8f8c3e1d430699580ff0978ff1c8e52fd47a5395f86029a","status":"ai_reviewed","primary_topic":"research","topics":[{"id":"research","evidence":"ic issues in evidence interpretation and the governance of scientific uncertainty. These analyses examine how differences in evidentiary framework"},{"id":"standards","evidence":"tructures that are currently responsible for setting limits are not well suited to registering that strength. The attached s"},{"id":"cancer","evidence":"dent research: an evidence assessment of the RF-EMF cancer and genotoxicity literature, and an analysis of the governance a"},{"id":"mechanisms","evidence":"coping review and evidence map of the RF-EMF genotoxicity literature, an independent assessment of the evidence concerning"},{"id":"smart-meters","evidence":"y are compared with symptoms reported in two smart-meter datasets: Lamech 2014, a peer-reviewed case series, and Halteman 2011, a "}],"summary":"The commenter outlines an evidence and governance critique of RF safety assurances, drawing on cancer, genotoxicity and exposure reports, and argues that institutional practices and funding influence interpretation without claiming established human carcinogenicity.","reviewed_at":"2026-10-21T23:43:28Z","review_method":"Complete submitted comment-text review with neutral attributed summaries and exact evidence; attachments and external materials not reviewed.","review_source_sha256":"e0920272fca486da47aca1ed0fc7a75cfc3eb8fa8fd6e175af81adbdcfad5ec2","source_url":"https://rfsafe.net/hhs-comments/data/catalog.json","scope":"Original comment body; attachments excluded"},"forum_topics":["research","standards","cancer","mechanisms","smart-meters"],"primary_topic":"research","forum_title":"The commenter outlines an evidence and governance critique of RF safety assurances, drawing on cancer, ge…"}